AI drug discovery
Computational target discovery, virtual screening, and generative drug design. Explore research source records, company profiles, and current public reviewed events with sources and dates preserved.
Topic labels are automated discovery categories for finding related material. They do not establish a company’s capabilities, causality, or clinical efficacy.
Research and industry source records
Sampling protein language models for functional protein design
Crossref REST API · Indexed academic record · Source published: Date not provided · Indexed here: Thu Oct 08 2026 09:31:31 GMT+0000 (Coordinated Universal Time)
Sampling protein language models for functional protein design
从AI预测到干湿闭环：AI for Science 正在跨越临界点
XtalPi official Chinese RSS · Indexed industry source record · Source published: Wed Oct 07 2026 03:30:18 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 05:44:17 GMT+0000 (Coordinated Universal Time)
科学哲学家卡尔·波普尔认为， 科学在猜想与反驳中向前发展 。提出一个新想法只是开始，接下来还得看它能否经得住检验。 如今，AI 让提出假设变得越来越快。候选药物分子、新材料结构，模型可以在短时间内给出大量方案。但在实验室里，确认它们是否有效，仍可能需要数周甚至数月。 AI 正在快速重构科研的上半场，验证能力渐渐成了卡住科研进度的新瓶颈 。这道难题，该如何解答？ 数字世界假设正在变得空前便利 MIT FutureTech 与 Google
活性提升超千倍！晶泰分子胶管线公布最新进展
XtalPi official Chinese RSS · Indexed industry source record · Source published: Tue Oct 06 2026 03:29:09 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 08:23:52 GMT+0000 (Coordinated Universal Time)
活性提升超千倍！晶泰分子胶管线公布最新进展 并结合计算和实验数据训练 AI 模型，对不同 E3-目标蛋白组合进行优先级判断。
Iambic Submits IND for a Potentially Brain-Penetrant KIF18A Inhibitor IAM217, Its Second Wholly Owned AI-Discovered Candidate
Iambic official newsroom · Indexed industry source record · Source published: Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:07:58 GMT+0000 (Coordinated Universal Time)
In nonclinical studies, IAM217 was observed to have potent and selective target engagement with a favorable drug-drug interaction profile IAM217 is believed to be brain penetrant, producing regression of established intr
Engineering human multi-organ tissue chip niches for drug absorption, distribution, metabolism, excretion and toxicity prediction.
PubMed / NCBI E-utilities · Indexed academic record · Source published: Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:09:29 GMT+0000 (Coordinated Universal Time)
Predicting human drug responses in vitro remains a central challenge in drug development. Animal models have shown limited accuracy in recapitulating human drug absorption, distribution, metabolism, excretion and toxicit
晶泰生发管线进入 IND-enabling 阶段：以极低浓度，解锁温和高效生发新可能
XtalPi official Chinese RSS · Indexed industry source record · Source published: Fri Oct 02 2026 02:52:02 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 05:44:17 GMT+0000 (Coordinated Universal Time)
晶泰科技（ 2228.HK ）今日宣布，其面向脱发治疗的创新药管线正式进入 IND-enabling（临床试验申请前准备）研究阶段。围绕候选分子的药效、安全性、成药性及 CMC 等关键要素的系统研究已经展开，为临床试验申请奠定基础。 据国家卫健委此前发布的数据，我国脱发人群已超过 2.5 亿，平均每 6 人中就有 1 人受脱发困扰。更值得关注的是，脱发正在明显年轻化——越来越多的 90 后、甚至 00 后，在人生早期阶段就开始面临发际线
FLIGHTED: Inferring fitness landscapes from noisy high-throughput experimental data.
PubMed / NCBI E-utilities · Indexed academic record · Source published: Fri Oct 02 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:09:22 GMT+0000 (Coordinated Universal Time)
Machine learning (ML) for protein design requires large protein fitness datasets generated by high-throughput experiments for training and benchmarking models. However, most models do not account for experimental noise i
Roswell Park, Generate Biomedicines Launch Exclusive Clinical Trial of ‘Armored’ CAR T Therapy for Ovarian Cancer
Generate Biomedicines official news-release RSS · Indexed industry source record · Source published: Thu Oct 01 2026 11:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:07:27 GMT+0000 (Coordinated Universal Time)
Engineered with AI to optimize T-cell function in solid tumors, GB-5267 is the first next-generation cell therapy for ovarian cancer to enter clinical trials First patient treated in new clinical trial underway at Roswel
Function-preserving watermarking of AI-generated proteins.
PubMed / NCBI E-utilities · Indexed academic record · Source published: Wed Sep 30 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:09:22 GMT+0000 (Coordinated Universal Time)
Generative artificial intelligence (AI) models are revolutionizing biology, with tools such as AlphaFold 3 and protein design models accelerating breakthroughs in protein structure prediction and the creation of new func
寻找下一个“十亿美金分子”科学创业大赛：XtalPi Science，高校年轻人的第一个创业合伙人
XtalPi official Chinese RSS · Indexed industry source record · Source published: Tue Sep 29 2026 07:54:08 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 05:44:17 GMT+0000 (Coordinated Universal Time)
符合要求的参赛团队将获得 XtalPi Science 启动 Token 支持。 经过实验验证并进入临床转化的优秀分子，有机会获得超亿元级现金投资。 近日，哈佛大学计算生物学博士 Douglas Yao 因在自家车库中借助 AI 和实验机器人推进候选药物研发，引发了广泛关注。 过去需要团队、实验室和大量专业工具才能完成的部分科研工作，正在被 AI 和自动化工具重新组织。一个科学想法，也开始有机会被更快地设计、验证，并继续向前推进。 一个
Building a new path to make medicines with AI
Isomorphic Labs official announcements · Indexed industry source record · Source published: Tue Sep 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:08:09 GMT+0000 (Coordinated Universal Time)
Listen: Spotify Apple Podcasts The Scale Solving all disease is one of the most monumentally complex challenges in science. Today, for the first time, AI provides the foundation to make it achievable. Tackling the fronti
Estonia and Owkin Partner to Advance Sovereign AI in Biology
Owkin official newsroom · Indexed industry source record · Source published: Tue Sep 29 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · Indexed here: Thu Oct 08 2026 09:08:00 GMT+0000 (Coordinated Universal Time)
Tallinn / Paris, 29 September 2026 – Estonia, led by the National Applied Research Center Metrosert, and Owkin today announced a collaboration to advance sovereign AI in biological and health research, working with Metro
Current public reviewed events
晶泰公布 XGlue 分子胶平台与临床前管线进展
Tue Oct 06 2026 03:29:09 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据晶泰官方 RSS 中的公告，XGlue 工作结合计算与实验数据训练 AI 模型，对 E3 与目标蛋白组合进行优先级判断；不把公司表述转换为临床疗效证据。
Iambic 提交第二款自有 AI 发现候选药 IAM217 的 IND
Mon Oct 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Iambic 官方公告，已提交 IAM217 的 IND 申请。提交申请不等于监管批准，也不代表临床疗效已获证实。
Absci 公布 AI 设计抗体 ABS-201 的 II 期试验初步计划
Thu Sep 24 2026 12:00:49 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Absci 官方公告，AI 设计抗体 ABS-201 的 II 期试验预计于 2027 年中启动。当前披露为初步计划，不能写成 II 期已经开展。
Iambic 与 AbbVie 宣布 AI 药物发现合作
Mon Sep 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据双方在 Iambic 官网发布的公告，将利用 Iambic 的 AI 平台合作开展药物发现，提高候选药物识别效率。属于公司宣布的合作，未独立验证研发成效。
Genentech 将与 Recursion 合作的首个神经科学靶点推进至联合早期发现
Wed Aug 05 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Recursion 官方公告，Genentech 已将双方合作的首个神经科学靶点推进至联合早期发现项目。属于研发阶段进展，不是临床试验结果。
Iambic 与拜耳合作推进 AI 小分子发现
Mon Jun 22 2026 00:00:00 GMT+0000 (Coordinated Universal Time) · 1 currently public evidence items
据 Iambic 官方公告，拜耳将通过合作使用 Iambic 的 AI 平台开展新药发现；尚非临床疗效结论。
Companies with related public source records
- XtalPi · AI, models, and data · 中国/美国
- Absci · AI, models, and data · 美国
- Emulate · Biopharma · 美国
- Generate Biomedicines · AI, models, and data · 美国
- Iambic Therapeutics · AI, models, and data · 美国
- Isomorphic Labs · AI, models, and data · 英国/美国
- NVIDIA · AI, models, and data · 全球
- Owkin · AI, models, and data · 法国/美国
Reader guides: from sources to conclusions
Compare models by task and follow collaborations through evidence. Each guide includes original sources and a review date.
How should we compare virtual cells, AI models, and companies?
Compare single-cell models, structure prediction, and protein design by inputs, outputs, tasks, and validation conditions. Distinguish model papers from company capabilities.
Reader guide · updated 2026-10-08
AI drug discovery collaboration timelines: from announcements to evidence
Use real official announcements to distinguish partners, upfront payments, conditional milestones, and R&D progress, and build a traceable collaboration timeline.
Reader guide · updated 2026-10-08
How to read weekly AI drug discovery updates: companies, research, and coverage gaps
Build a weekly reading routine, distinguish announcements, papers, and clinical results, and understand this site’s weekly indexing window, denominators, and source coverage.
Reader guide · updated 2026-10-08